News

FDA Says Lettuce Recall Was a False Positive; Apple Gets a Bullish Call on Its AI Strategy

The FDA reversed course on a cyclospora finding in Taylor Farms lettuce, calling it a false positive. Meanwhile, HSBC upgraded Apple, citing the company's "anti-capex" AI advantage, as Apple also filed a trade-secret lawsuit against OpenAI.

OurAlpha

20 Jul 2026 — 3 min read

The FDA says a lettuce test was a false positive, while Apple's AI strategy gets a Wall Street upgrade.

The FDA said Monday that a cyclospora finding in Taylor Farms lettuce was a false positive, potentially narrowing a massive recall. Separately, HSBC upgraded Apple (AAPL), arguing its "anti-capex" AI strategy is a competitive edge. Apple closed at $333.74 on Friday, up 0.14%.

The FDA confirmed a cyclospora test on Taylor Farms lettuce was a false positive, unrelated to the samples that triggered the initial five-state recall.^[Reuters]
Taylor Farms had previously expanded its iceberg lettuce recall to 27 states over potential cyclospora contamination.^{[NBC News]}
HSBC issued a bullish note on Apple, arguing its reliance on Google’s AI infrastructure gives it an "anti-capex" advantage, avoiding massive hardware investments.^[CNBC]
Apple filed a trade-secret lawsuit against OpenAI on Friday, alleging the poaching of over 400 former Apple employees, a move that could disrupt OpenAI's IPO plans.^[TechCrunch]
As of Friday's close, Apple (AAPL) was at $333.74, up 0.14% (+$0.48) from its prior close of $333.26, with an intraday range of $329.00 to $334.99. U.S. markets were closed Monday for a holiday.

The FDA reversed course Monday, saying a cyclospora finding in Taylor Farms lettuce was a false positive, a move that could ease a recent food-safety scare. At the same time, Apple (AAPL) got a Wall Street upgrade from HSBC, which praised its "anti-capex" AI strategy. Apple closed Friday at $333.74, up 0.14%, with an intraday range of $329.00 to $334.99. Markets were closed Monday for a U.S. holiday, so the stock is quoted at that closing price with no real-time trading.^[^MarketBeat^]

FDA Reversal: False Positive and an Expanded Recall

The FDA said Monday that a cyclospora test on Taylor Farms lettuce was a false positive. Reuters reported the finding was unrelated to the samples that triggered the initial five-state recall.^[^Reuters^] However, just a day earlier, NBC News reported that Taylor Farms had expanded its iceberg lettuce recall to 27 states over concerns of cyclospora, a parasite that can cause severe gastrointestinal illness.^[^{NBC News}^] That expansion happened before the FDA's false-positive announcement, sparking debate over food-safety protocols. Taylor Farms and Taco Bell have since removed the affected lettuce from their menus.

HSBC Upgrades Apple: The 'Anti-Capex' AI Advantage

CNBC reported that HSBC issued a bullish note on Apple, arguing its AI strategy gives it an "anti-capex" advantage.^[^CNBC^] The report says Apple, unlike other tech giants, isn't building its own AI data centers. Instead, it's relying on Google's AI infrastructure. This lets Apple avoid massive capital expenditures while still getting access to advanced AI capabilities. CNBC's MacKenzie Sigalos noted the strategy could further boost Apple's stock. The report also suggested potential DOJ settlement talks could provide additional support for the stock.

Apple Sues OpenAI: Trade Secret Dispute Could Hit IPO

TechCrunch reported that Apple filed a trade-secret lawsuit against OpenAI on Friday, alleging a pattern of misconduct.^[^TechCrunch^] The suit claims OpenAI's hardware chief was involved, and that over 400 former Apple employees have jumped to OpenAI. Apple's allegations involve "systematic misconduct," while OpenAI's response has been "cautious and reserved." TechCrunch's Equity podcast argues the timing is terrible for OpenAI, which is planning an IPO as early as later this year. The lawsuit could significantly disrupt its hardware ambitions and IPO timeline.

Macro Backdrop: Geopolitics and Earnings Season

CNBC's "Today's Call Sheet" discussed factors that could drive trading this week, including the escalating U.S.-Iran conflict, the strength of tech and AI themes, and the upcoming peak of earnings season.^[^CNBC^] Although Apple had no real-time trading during the holiday, market participants are watching how these macro variables will affect the tech sector's overall sentiment. Analysts Peter Tchir (Academy Securities), Adam Crisafulli (Vital Knowledge), and Ryan Detrick (Carson Group) discussed these issues on the program, setting the tone for the week's trading.